Summary
To resolve whether haemoglobin A 1c (HbA 1c ) levels have arisen from less rigorous categorization of subjects than we used, resulting in the inclusion of in normal subjects increase with age, we measured HbA 1c in 399 patients undergoing routine oral glusome individuals with IGT or diabetes in the 'normal' groups of other studies. The prevalence of cose tolerance test (OGTT). The OGTT results categorized the patients into 127 normal, 94 impaired such abnormality would be expected to be greater amongst older subjects, falsely suggesting a correlaglucose tolerance (IGT) and 178 diabetic. None of these groups showed a significant correlation tion between HbA 1c and age, and we were able to demonstrate this with our own data when insuffibetween HbA 1c and age and we cannot, therefore, see a need for age-specific reference ranges for ciently rigorous criteria were applied for the selection of normal subjects. HbA 1c . Some of the confusion in the literature may
Introduction
In a small study of 48 subjects above 50 years old, discovered during the study.3 We decided, therefore, to re-examine the situation in subjects who had been sub-divided into three age groups, Arnetz et al. observed significant differences in HbA1c levels classified by means of an oral glucose tolerance test (OGTT) performed and interpreted according to between the groups, the oldest having the highest values.1 In contradiction to this, Kabadi found no World Health Organization recommendations.5 significant relationships between age and fasting plasma glucose (FPG), glycated haemoglobin, glycated protein or glycated albumin.2 A large French Methods study of 3240 individuals in a working population, the Telecom study, concluded that age independently Our subjects comprised 399 patients who had been routinely referred for OGTT. The test was performed influenced HbA 1c
.3 Yet another group of workers reported that haemoglobin A 1c (HbA 1c ) showed a and interpreted according to WHO protocol with the classification of the patient being based on the positive linear relationship with age in non-diabetic individuals, whereas fructosamine did not.4 If such 2-h glucose result.5 Blood for glucose assay was collected by finger prick into fluoride preservative, a relationship exists, one implication is that reference ranges for HbA 1c would need to be age-specific. and plasma from this was used for measurement on an Analox GM7 glucose analyser (Analox While the evidence seems strongly in favour of age influencing HbA 1c , most of these studies can be Instruments) or a Beckman Glucose Analyzer (Beckman Instruments). The same blood samples criticised either for selecting subjects in a way that would include some with abnormal glucose tolerwere used for HbA 1c measurement by means of Daiichi HA-8121 or HA-8140 high performance ance,1,4 or for not excluding individuals whose diabetes or impaired glucose tolerance (IGT) was ion-exchange chromatography (HIPEC) analysers (Biomen) with between-batch CV of less than 2% at versus age for the normal cohort, r=0. able when FPG is plotted against age for the normal subjects (Figure 2 ), but 2 h plasma glucose against age does not show a significant correlation (r= Results 0.026; NS) (Figure 3 ). After performing the OGTT, the 399 patients were
If we had taken all individuals with FPG categorized into the following three groups: normal <6.4 mmol/l as our normal group, the number (127), IGT (94) and diabetic (178). Figure 1 shows would have increased to 194 by including a proporHbA 1c results for these three groups plotted against tion of patients with abnormal 2 h plasma glucose, age and there is no significant positive relationship but also excluding some with normal 2 h plasma glucose whose FPG was >6.4 mmol/l. A plot of with age for any of the groups. In the case of HbA 1c , Figure 1 . HbA 1c results plotted against age separately for normal, IGT and diabetic subjects. (Figure 4) , as would groups, but in the diabetic cohort there was a greater a plot of 2 h plasma glucose versus age (r=0.309; concentration of subjects from the middle to the p<0.001), but this also shows that 26 had diabetes older end of the age range, as would be predicted. and 55 had IGT and were, therefore, not normal Our data for normal subjects hinted at a very weak ( Figure 5 ). In total, almost 42% of the subjects who correlation for FPG with age. Although it might be would have been classified as normal by FPG expected that the OGTT would emphasize any such <6.4 mmol/l were either diabetic or had IGT, relationship, no correlation was observed between according to their responses in the OGTT.
2 h plasma glucose and age. Selection of subjects may be the key to the differences in findings between our study and those
Discussion
where age was considered to have an influence on The findings of our study do not lend support to the HbA 1c .1,3,4 In our case, they were all non-pregnant suggestion that HbA 1c increases with age per se. individuals referred, mostly by general practitioners, for OGTT because of a suspicion that they might None of the three groups of patients (non-diabetic, have diabetes. The reasons for this suspicion were dependent diabetes increases with age, it would be expected that such individuals, inadvertently and very varied, but included family history, glycosuria and other symptoms possibly attributable to diabetes.
incorrectly included in the 'normal' group, would be predominantly at the older end of the age Nevertheless, our group of normal subjects did have convincing evidence, in the form of the OGTT result, spectrum and would produce an apparent correlation between HbA 1c and age per se. Indeed, this phenomthat they were indeed normal, i.e. neither diabetic nor IGT. The subjects in the study of Kilpatrick et al.4 enon was demonstrated in our own patients when all with FPG <6.4 mmol/l were grouped together. were classified as normal simply on the basis of FPG <6.4 mmol/l, and this alone is not a sufficiently Similarly, significant positive correlation between 2 h plasma glucose and age became apparent when all rigorous criterion to exclude all diabetics and individuals with IGT.6,7 Consequently, it is likely that subjects with FPG <6.4 mmol/l were included, but some of these had diabetes and others had IGT. The their cohort contained some people with diminished glucose tolerance. This is even more likely in the large Telecom population study was also compromised by the inclusion of people with impairment of study of Arnetz et al. where a cut-off for FPG as high as 7.2 mmol/l was used for the selection of glucose tolerance.3 Although previously-known diabetics were excluded, over 7% of individuals normal subjects.1 As the incidence of non-insulin-included were found to have IGT or diabetes, and
In conclusion, we were unable to detect any direct relationship between age and HbA 1c measured these would be expected to be mostly in the older age groups, enhancing the apparent correlation of by ion-exchange chromatography in groups of subjects carefully categorized by OGTT. Hence, we HbA 1c with age. This does not, however, provide an explanation cannot support claims that age-related reference ranges may be needed for HbA 1c . It is certainly true of why fructosamine and FPG did not correlate with age in the study of Kilpatrick et al. if they had that there is a greater incidence of impaired glucose tolerance and diabetes among older people, and the included some subjects with diminished glucose tolerance. We did not measure fructosamine; our reported relationship between age and HbA 1c is probably secondary to this. findings with FPG suggested a weak correlation existed between this parameter and age in our normal subjects classified by OGTT, but the relationship was not very convincing.
There is a fundamental difference in the ways that
